To address these issues, and the underlying unmet needs, we together with the R3i International Steering Committee and National Steering Committees members, developed a unique model built upon the principles of academic research, education and advocacy. We are happy to report that while much work remains on all fronts we are making real progress: • Research studies have been initiated that will provide new information about dyslipidemia and residual vascular risk • Nearly 400 opinion leaders in 48 countries have signed on to the challenge (202 National Steering Committee members and 156 National Faculty members) • Thousands of clinicians have been exposed to the R3i messages in 2009 through personal and non-personal venues at R3i meetings, congresses, and through the use of today’s modern communication technologies • Finally, encouraging first contacts were made with potential new grantors We strongly believe that if we continue to pursue all of these activities aggressively we will reach our goal of substantially extending and improving the lives of patients with heart disease and/or diabetes who have atherogenic dyslipidemia.
Pr. Jean-Charles Fruchart President Pasteur Institute, Lille, France
Pr. Frank Sacks Vice-President Harvard School of Public Health Boston, USA
Pr. Michel Hermans General Secretary Cliniques Universitaires Saint- Luc Brussels, Belgium
1. Atlas of Heart Disease and Stroke, WHO, September 2004. 2. Morrish NJ et al. Diabetologia 2001;44 Suppl 2:S14-S21. 3. Baigent C, Keech A, Kearney PM, et al, Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy and safety of cholesterol‐lowering treatment: prospective meta‐analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005;366:1267 1278. 4. Cholesterol Treatment Trialists’ (CTT) Collaborators, Kearney PM, Blackwell PM, Collins R, et al. Efficacy of cholesterol lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta analysis. Lancet 2008;371:117 125. 5. Fact Sheet Diabetes and Eye Disease. IDF. http://www.idf.org/fact-sheet-diabetes-and-eye-disease (Accessed November 2009) 6. International Diabetes Federation. Did you Know – The human, social and economic impact of diabetes [fact sheet on the Internet]. International Diabetes Federation, Brussels c 2008. [Last accessed 8th October 2008]. Available at: http://www.idf.org/home/index.cfm?node=41. 7. Diabetes and Kidney Disease: Time to Act. IDF, 2003.
3